STEPHEN A HURLY
CIK 1130637 · Chief Executive Officer · last filed 2025-11-17
STEPHEN A HURLY is a Chief Executive Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for LVTX, was dated Nov 17, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV (LVTX) Delisted | Chief Executive Officer | 0 | $1.74 | $0 | $0 | 2 | 2025-11-17 |
| Carisma Therapeutics Inc. (SESN) Delisted | President and CEO | — | $12.58 | — | $0 | 1 | 2018-06-14 |
| Carisma Therapeutics Inc. (EBIO) Delisted | President and CEO | 398,031 | — | — | $0 | 5 | 2018-04-11 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-17 | LAVA Therapeutics NV (LVTX) Delisted | Disp (D) | −5,000 | $0 | EDGAR |
| 2025-02-18 | LAVA Therapeutics NV (LVTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | Carisma Therapeutics Inc. (SESN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-11 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-16 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-22 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-05 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-22 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | +398,031 | $0 | EDGAR |